Table 1. Distribution of patients based on demographic and clinical characteristics.
| Demographic and clinical parameters | Patients (n = 60) |
| Age (year ± SD) | 52.85 ± 10.42 |
| Female, n (%) | 23 (38.3) |
| BMI (kg/m2 ± SD) | 24.63 ± 2.8 |
| Smoking, n (%) | 32 (53.3) |
| Drinking, n (%) | 29 (48.3) |
| Hyperlipidaemia, n (%) | 27 (45.0) |
| Diabetes mellitus n (%) | 8 (13) |
| Antihypertensive drugs | |
| ACEI, n (%) | 21 (35.0) |
| ARB, n (%) | 20 (33.3) |
| BB, n (%) | 24 (40.0) |
| CCB, n (%) | 22 (36.6) |
| HDL-C (mg/dl ± SD) | 47.63 ± 13.21 |
| (mmol/l) | 1.23 ± 0.34 |
| LDL-C (mg/dl ± SD) | 133.55 ± 40.91 |
| (mmol/l) | 3.46 ± 1.06 |
| FPG (mg/dl ± SD) | 95.82 ± 15.04 |
| (mmol/l) | 5.32 ± 0.83 |
| TG (mg/dl ± SD) | 132.16 ± 74.34 |
| (mmol/l) | 1.49 ± 0.84 |
| Total cholesterol (g/dl ± SD) | 185.16 ± 42.7 |
| (mmol/l) | 4.80 ± 1.11 |
| Creatinine (mg/dl ± SD) | 0.79 ± 0.18 |
| (mmol/l) | 69.84 ± 15.91 |
| Haemoglobin (g/dl ± SD) | 13.6 ± 1.61 |
| Ejection fraction (% ± SD) | 66.61 ± 3.8 |
Continuous data are expressed as mean ± SD, categorical data are expressed as n (%). SD: standard deviation, ACEI: angiotensin converting enzyme inhibitors, ARB: angiotensin receptor blocker, BB: beta-blocker, CCB: calcium channel blockers, HDL-C: high-density lipoprotein cholesterol, LDL-C: low-density lipoprotein cholesterol, FPG: fasting plasma glucose, TG: triglycerides.